<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">oncotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский онкологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian journal of oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-4861</issn><issn pub-type="epub">2312-3168</issn><publisher><publisher-name>Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">oncotomsk-30</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОПЫТ РАБОТЫ ОНКОЛОГИЧЕСКИХ УЧРЕЖДЕНИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ONCOLOGY PRACTICE</subject></subj-group></article-categories><title-group><article-title>ДИАГНОСТИКА ЭКСТРАНОДАЛЬНЫХ ПОРАЖЕНИЙ ПРИ ЛИМФОМАХ С ПОМОЩЬЮ СОВМЕЩЕННОЙ ПЭТ-КТ</article-title><trans-title-group xml:lang="en"><trans-title>DETECTION OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH LYMPHOMAS USING THE COMBINED PET-CT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Важенин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vazhenin</surname><given-names>А. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>454087, г. Челябинск, ул. Блюхера, 42</p></bio><bio xml:lang="en"><p>42, Blyukhera Street, 454000-Chelyabinsk</p></bio><email xlink:type="simple">acsubbotin@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Афанасьева</surname><given-names>Н. Г.</given-names></name></name-alternatives><bio xml:lang="ru"><p>454087, г. Челябинск, ул. Блюхера, 42</p></bio><email xlink:type="simple">acsubbotin@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Субботин</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Subbotin</surname><given-names>А. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>454087, г. Челябинск, ул. Блюхера, 42</p></bio><bio xml:lang="en"><p>42, Blyukhera Street, 454000-Chelyabinsk</p></bio><email xlink:type="simple">acsubbotin@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Челябинский окружной клинический онкологический диспансер», г. Челябинск&#13;
454087, г. Челябинск, ул. Блюхера, 42</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Челябинский окружной клинический онкологический диспансер», г. Челябинск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>07</day><month>02</month><year>2016</year></pub-date><volume>0</volume><issue>2</issue><fpage>36</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Важенин А.В., Афанасьева Н.Г., Субботин А.С., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Важенин А.В., Афанасьева Н.Г., Субботин А.С.</copyright-holder><copyright-holder xml:lang="en">Vazhenin А.V., Афанасьева Н.Г., Subbotin А.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.siboncoj.ru/jour/article/view/30">https://www.siboncoj.ru/jour/article/view/30</self-uri><abstract><p>Представлен опыт Центра позитронно-эмиссионной томографии Челябинского окружного клинического онкологического диспансера в диагностике экстранодальных поражений при лифмомах. ПЭТ-КТ исследование проведено 316 пациентам с лимфомами Ходжкина и неходжкинскими лимфомами, в 43,6 % случаев выявлены экстранодальные поражения. При их оценке учитывались стандартизованный уровень накопления (SUVmax), характер поражения (очаговое или диффузное) и наличие структурного субстрата, выявляемого с помощью КТ-компонента исследования (кроме очагов метаболической активности без четко визуализируемого морфологического субстрата).</p></abstract><trans-abstract xml:lang="en"><p>The experience of the Center of Positron Emission Tomography of Chelyabinsk Regional Clinical Oncology Center in the diagnosis of extranodal involvement in patients with lymphomas has been presented. Three hundred and sixteen patients with Hodgkin’s and nonHodgkin’s lymphomas underwent a PET-CT examination, which revealed extranodal involvement in 43.6% of cases. The standardized uptake value (SUVmax), nature of the lesion (focal or diffuse) and the presence of structural substrate detected on the CT component of the study (except metabolic activity foci without clearly visualized morphological substrate) were taken into account.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лимфома</kwd><kwd>экстранодальная локализация</kwd><kwd>совмещенная ПЭТ-КТ</kwd><kwd>18-F ФДГ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lymphoma</kwd><kwd>extranodal localization</kwd><kwd>combined 18-F-FDG-PET-CT</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2012 году. М., 2013. 232 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinskij V.V., Petrova G.V. Cancer care in Russia in 2012. М., 2013. 232 p. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Имянитов Е.Н. Эпидемиология и биология лимфомы Ходжкина // Практическая онкология. 2007. Т. 8, № 2. С. 53–56.</mixed-citation><mixed-citation xml:lang="en">Imjanitov E.N. Epidemiology and biology of Hodgkin’s lymphoma // Prakticheskaja onkologija. 2007. Vol. 8 (2). P. 53–56. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков С.Н., Гиршович М.М. Диагностика и стадирование лимфомы Ходжкина // Практическая онкология. 2007. Т. 8, № 2. С. 65–72.</mixed-citation><mixed-citation xml:lang="en">Novikov S.N., Girshovich M.M. Diagnosis and staging of Hodgkin’s lymphoma // Prakticheskaja onkologija. 2007. Vol. 8 (2). P. 65–72. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Поддубная И.В., Дёмина Е.А. Диагностика и определение распространенности (стадирование) неходжкинских лимфом // Практическая онкология. 2004. Т. 5, № 3. С. 176–184.</mixed-citation><mixed-citation xml:lang="en">Poddubnaja I.V., Djomina E.A. Diagnosis and staging of nonHodgkin’s lymphoma // Prakticheskaja onkologija. 2004. Vol.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Тюрин И.Е. Диагностическая онкорадиология // Практическая онкология. 2007. Т. 8, № 4. С. 188–193.</mixed-citation><mixed-citation xml:lang="en">5 (3). P. С. 176–184. [in Russian] 5. Tjurin I.E. Diagnostic radiation oncology // Prakticheskaja onkologija. 2007. Vol. 8 (4). P. С. 188–193. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Хансон К.П., Имянитов Е.Н. Эпидемиология и биология неходжкинских лимфом // Практическая онкология. 2004. Т. 5, №3. С. 163–168.</mixed-citation><mixed-citation xml:lang="en">Hanson K.P., Imjanitov E.N. Epidemiology and biology of nonHodgkin’s lymphoma // Prakticheskaja onkologija. 2004. Vol. 5 (3). P. 163–168. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Beal K.P., Yeung H.W., Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases // Ann. Oncol. 2005. Vol. 16 (3). P. 473–480.</mixed-citation><mixed-citation xml:lang="en">Beal K.P., Yeung H.W., Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases // Ann. Oncol. 2005. Vol. 16 (3). P. 473–480.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ben-Haim S., Bar-Shalom R., Israel O., Gaitini D., Haim N., Epelbaum R., Even-Sapir E., Jerushalmi J., Gips S., Kolodny G.M. Liver Involvement in Lymphoma: Role of Gallium-67 Scintigraphy // J. Nucl. Med. 1995. Vol. 36 (5). P. 900–904.</mixed-citation><mixed-citation xml:lang="en">Ben-Haim S., Bar-Shalom R., Israel O., Gaitini D., Haim N., Epelbaum R., Even-Sapir E., Jerushalmi J., Gips S., Kolodny G.M. Liver Involvement in Lymphoma: Role of Gallium-67 Scintigraphy // J. Nucl. Med. 1995. Vol. 36 (5). P. 900–904.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Berkman N., Breuer R., Kramer M.R., Polliack A. Pulmonary involvement in lymphoma // Leukemia. Lymphoma. 1996. Vol. 20 (3–4). P. 229–237.</mixed-citation><mixed-citation xml:lang="en">Berkman N., Breuer R., Kramer M.R., Polliack A. Pulmonary involvement in lymphoma // Leukemia. Lymphoma. 1996. Vol. 20 (3–4). P. 229–237.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">De Jong P.A., van Ufford H.M., Baarslag H.J., de Haas M.J., Wittebol S.H., Quekel L.G., de Klerk J.M. CT and 18F-FDG PET for Noninvasive Detection of Splenic Involvement in Patients with Malignant Lymphoma // AJR. 2009. Vol. 192 (3). P. 745–753. doi: 10.2214/AJR.08.1160.</mixed-citation><mixed-citation xml:lang="en">De Jong P.A., van Ufford H.M., Baarslag H.J., de Haas M.J., Wittebol S.H., Quekel L.G., de Klerk J.M. CT and 18F-FDG PET for Noninvasive Detection of Splenic Involvement in Patients with Malignant Lymphoma // AJR. 2009. Vol. 192 (3). P. 745–753. doi: 10.2214/AJR.08.1160.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dhanapathi H., Kumar R. F-18 FDG PET/PET-CT in the Management of Lymphoma // Ind. J. Med. Paediatr. Oncol. 2007. № 3. P. 17–23.</mixed-citation><mixed-citation xml:lang="en">Dhanapathi H., Kumar R. F-18 FDG PET/PET-CT in the Management of Lymphoma // Ind. J. Med. Paediatr. Oncol. 2007. № 3. P. 17–23.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Even-Sapir E., Lievshitz G., Perry C., Herishanu Y., Lerman H., Metser U. Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin’s Disease // Radiol. Clin. 2007. № 45. P. 697–709.</mixed-citation><mixed-citation xml:lang="en">Even-Sapir E., Lievshitz G., Perry C., Herishanu Y., Lerman H., Metser U. Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin’s Disease // Radiol. Clin. 2007. № 45. P. 697–709.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ilica A.T., Kocacelebi K., Savas R., Ayan A. Imaging of extranodal lymphoma with PET/CT // Clin. Nucl. Med. 2011. Vol. 36 (10). P. 127–138. doi: 10.1097/RLU.0b013e31821c99cd.</mixed-citation><mixed-citation xml:lang="en">Ilica A.T., Kocacelebi K., Savas R., Ayan A. Imaging of extranodal lymphoma with PET/CT // Clin. Nucl. Med. 2011. Vol. 36 (10). P. 127–138. doi: 10.1097/RLU.0b013e31821c99cd.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Krol A.D., le Cessie S., Snijder S., Kluin-Nelemans J.C., Kluin P.M., Noordijk E.M. Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry // Ann. Oncol. 2003. № 14. P. 131–139.</mixed-citation><mixed-citation xml:lang="en">Krol A.D., le Cessie S., Snijder S., Kluin-Nelemans J.C., Kluin P.M., Noordijk E.M. Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry // Ann. Oncol. 2003. № 14. P. 131–139.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Metser U., Goor O., Lerman H., Naparstek E., Even-Sapir E. PETCT of Extranodal Lymphoma // AJR. 2004. Vol. 182 (6). P. 1579–1586.</mixed-citation><mixed-citation xml:lang="en">Metser U., Goor O., Lerman H., Naparstek E., Even-Sapir E. PETCT of Extranodal Lymphoma // AJR. 2004. Vol. 182 (6). P. 1579–1586.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nihashi T., Hayasaka K., Itou T., Ito K., Kato R., Okae T., Ishigaki T. Findings of fluorine-18-FDG PET in extranodal origin lymphoma. In three cases of diffuse large B cell type lymphoma // Ann. Nucl. Med. 2006. Vol. 20 (10). P. 689–693.</mixed-citation><mixed-citation xml:lang="en">Nihashi T., Hayasaka K., Itou T., Ito K., Kato R., Okae T., Ishigaki T. Findings of fluorine-18-FDG PET in extranodal origin lymphoma. In three cases of diffuse large B cell type lymphoma // Ann. Nucl. Med. 2006. Vol. 20 (10). P. 689–693.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Paes F.M., Kalkanis D.G., Sideras P.A., Serafini A.N. FDG PET/ CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease // RadioGraphics. 2010. № 30. P. 269–291. doi: 10.1148/ rg.301095088.</mixed-citation><mixed-citation xml:lang="en">Paes F.M., Kalkanis D.G., Sideras P.A., Serafini AN. FDG PET/ CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease // RadioGraphics. 2010. № 30. P. 269–291. doi: 10.1148/ rg.301095088.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Schwaiger M., Wieder H. Role of PET in Lymphoma // Chang Gung Med. J. 2005. № 5. P. 315–325.</mixed-citation><mixed-citation xml:lang="en">Schwaiger M., Wieder H. Role of PET in Lymphoma // Chang Gung Med. J. 2005. № 5. P. 315–325.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zucca E., Roggero E., Bertoni F., Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas // Ann. Oncol. 1997. № 8. P. 727–737.</mixed-citation><mixed-citation xml:lang="en">Zucca E., Roggero E., Bertoni F., Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas // Ann. Oncol. 1997. № 8. P. 727–737.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
